269 related articles for article (PubMed ID: 10499557)
1. Optimal nitrate therapy with a once-daily sustained-release formulation of isosorbide mononitrate.
Waller DG
J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 2():S21-7; discussion S29-31. PubMed ID: 10499557
[TBL] [Abstract][Full Text] [Related]
2. Short and long-acting oral nitrates for stable angina pectoris.
Thadani U; Lipicky RJ
Cardiovasc Drugs Ther; 1994 Aug; 8(4):611-23. PubMed ID: 7848896
[TBL] [Abstract][Full Text] [Related]
3. Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.
Silber S
Eur J Clin Pharmacol; 1990; 38 Suppl 1():S35-51. PubMed ID: 2113003
[TBL] [Abstract][Full Text] [Related]
4. Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.
Gunasekara NS; Noble S
Drugs; 1999 Feb; 57(2):261-77. PubMed ID: 10188765
[TBL] [Abstract][Full Text] [Related]
5. Long-acting isosorbide mononitrate.
Prakash A; Markham A
Drugs; 1999 Jan; 57(1):93-9; discussion 100. PubMed ID: 9951954
[TBL] [Abstract][Full Text] [Related]
6. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group.
Cleophas TJ; Niemeyer MG; Zwinderman AH; van der Wall EE
Angiology; 2000 Aug; 51(8):631-8. PubMed ID: 10959515
[TBL] [Abstract][Full Text] [Related]
7. Sustained-release isosorbide mononitrate (50 mg): optimization of a once-daily dosage form for long-term treatment of angina pectoris.
Bonn R
Am J Cardiol; 1988 Mar; 61(9):12E-14E. PubMed ID: 3348135
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
Chrysant SG; Glasser SP; Bittar N; Shahidi FE; Danisa K; Ibrahim R; Watts LE; Garutti RJ; Ferraresi R; Casareto R
Am J Cardiol; 1993 Dec; 72(17):1249-56. PubMed ID: 8256699
[TBL] [Abstract][Full Text] [Related]
9. A sustained release formulation of isosorbide-5-mononitrate with a rapid onset of action.
Arthur RM; Mehmel H
Int J Clin Pract; 1999; 53(3):205-12. PubMed ID: 10665134
[TBL] [Abstract][Full Text] [Related]
10. Absence of pre-dose rebound phenomena with once daily 5-ISMN in a controlled-release formulation.
Olsson G; Allgén J; Amtorp O; Nyberg G; Parker JO
Eur Heart J; 1992 Jun; 13(6):814-7. PubMed ID: 1623873
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of isosorbide mononitrate in angina pectoris.
Thadani U; de Vane PJ
Am J Cardiol; 1992 Nov; 70(17):67G-71G. PubMed ID: 1449103
[TBL] [Abstract][Full Text] [Related]
12. Nitrate tolerance--can it be prevented?
Parker JO
Eur Heart J; 1991 May; 12 Suppl A():13-5. PubMed ID: 1874269
[TBL] [Abstract][Full Text] [Related]
13. Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure.
Thadani U
Cardiovasc Drugs Ther; 1997 Jan; 10(6):735-42. PubMed ID: 9110117
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 50-mg and 100-mg sustained-release isosorbide mononitrate in the treatment of stable angina pectoris: effects on quality-of-life indices. Dutch Mononitrate Quality of Life (DUMQOL) Study Group.
Zwinderman AH; Cleophas TJ; van der Sluijs H; Niemeyer MG; Buunk BP; van der Wall EE
Angiology; 1999 Dec; 50(12):963-9. PubMed ID: 10609762
[TBL] [Abstract][Full Text] [Related]
15. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
Thadani U
Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with Imdur in angina pectoris. A review.
Nyberg G
Eur J Clin Pharmacol; 1990; 38 Suppl 1():S65-8. PubMed ID: 1972359
[TBL] [Abstract][Full Text] [Related]
17. [Lack of tolerance development in interval therapy with 50 mg isosorbide-5-nitrate retard (Elantan long)].
Jansen W; Prenzel R; Kümper H; Weidmann B; Tauchert M
Z Kardiol; 1989; 78 Suppl 2():72-8; discussion 115-7. PubMed ID: 2511697
[TBL] [Abstract][Full Text] [Related]
18. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
19. What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance?
Kośmicki M; Sadowski Z; Szwed H; Kowalik I
Med Sci Monit; 2000; 6(4):763-8. PubMed ID: 11208406
[TBL] [Abstract][Full Text] [Related]
20. When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness?
Rudolph W; Dirschinger J; Reiniger G; Beyerle A; Hall D
Eur Heart J; 1988 Jan; 9 Suppl A():63-72. PubMed ID: 3137072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
